IVDR-certified and clinically proven: Devyser RHD
RhD incompatibility remains a critical concern in prenatal care, with the potential to cause...
We help laboratories focus on what matters most to patients – correct and fast diagnosis every time. Our genetic test kits with integrated software set new standards in DNA diagnostic testing.
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden
News | June 26, 2025
Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant researchNews | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in ChinaRhD incompatibility remains a critical concern in prenatal care, with the potential to cause...
Read more
Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation...
Read more
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of...
Read more
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
Read more